undefined undefined
NaN.000
NaN.00%
Wells Fargo analyst Joseph O'Dea maintains Lennox Intl (NYSE:LII) with a Overweight and raises the price target from $520 to $550.
05-17 22:17
Harmony Biosciences (NASDAQ:HRMY) has acquired privately held Epygenix Therapeutics, which is focused on developing treatments for rare epilepsy conditions. Terms are that Harmony paid $35M upfront. E...
04-30 20:53
Lead Candidate, EPX-100, Holds Orphan Drug and Rare Pediatric Disease Designations EPX-100 in Pivotal Registrational Trial for Dravet Syndrome; Topline Data Expected in 2026 Plan to Initiate Phase 3 Trial for
04-30 19:14
Unity Software(U.US) reported fourth-quarter financial results after the market...
04-25 22:27
Lennox shares are trading lower after the company reported mixed Q1 financial r...
04-25 00:31
Lennox press release (NYSE:LII): Q1 Non-GAAP EPS of $3.47 beats by $0.31. Revenue of $1.05B in-line (flat Y/Y). GAAP Operating Income $167 million; adjusted segment profit up 17% to $167 million. Adju...
04-24 18:46
Q1 Highlights (All comparisons are year-over-year, unless otherwise noted) (Prior-year adjusted results and core revenue exclude European operations that were divested in the 4Q 2023) Revenu...
04-24 18:45
U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Tuesday.
04-16 18:53
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
04-10 20:34
Keybanc:维持Lennox Intl(LII.US)评级,由增持调整至增持评级, 目标价由500.00美元调整至515.00美元。
04-10 16:32